Director
Simeon J. George, M.D., M.B.A.
Simeon J. George, M.D., M.B.A. has served on our Board of Directors since April 2015. He is the Chief Executive Officer and Managing Partner of SR One Capital Management, LP, a transatlantic biotech venture capital firm, a role he has held since September 2020. Prior to leading SR One as an independent firm, Dr. George served as Chief Executive Officer and President of S.R. One, Limited (now GSK Equity Investments, Limited), an indirect, wholly owned subsidiary of GlaxoSmithKline plc, where he had been employed since 2007.
Dr. George co-founded Nkarta, Inc. (NKTX), a clinical-stage biopharmaceutical company, and currently serves on its board of directors—a position he has held since February 2020 (and previously from July 2015 to September 2017). He also serves on the board of Design Therapeutics, Inc. (DSGN), another clinical-stage biopharmaceutical company. Previously, Dr. George has served on the boards of Principia Biopharma Inc., Progyny, Inc. (PGNY), and Turning Point Therapeutics, Inc., among others.
Earlier in his career, Dr. George worked as a consultant at Bain & Company and in investment banking at Goldman Sachs. He earned his M.D. from the University of Pennsylvania School of Medicine and his M.B.A. from the Wharton School of the University of Pennsylvania. He also holds a B.A. in Neuroscience from Johns Hopkins University.
